Sagimet Biosciences (SGMT) Revenue (2023)

Sagimet Biosciences (SGMT) recorded quarterly Revenue of $2.0 million in Q3 2023.

Sagimet Biosciences (SGMT) Revenue (2023) Analysis & Trends

Sagimet Biosciences' Revenue history runs 1 years deep, the most recent figure standing at $2.0 million for Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 5.21 Mn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 306.30 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 2.99 Bn
9 Abivax 95.45 Bn 95.45 Bn - -
10 Sagimet Biosciences 212.94 Mn 212.94 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 2.00 Mn